menu
    • menu

    Company profile for MoonLake Immunotherapeutics

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody®1 technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.MoonLake has a portfolio of therapeutic programs based on the phase 3-ready Nanobody® Sonelokimab (SLK, M1095/ALX-0761), a biologic molecule potentially capable of driving disease modification in der...
    MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody®1 technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.MoonLake has a portfolio of therapeutic programs based on the phase 3-ready Nanobody® Sonelokimab (SLK, M1095/ALX-0761), a biologic molecule potentially capable of driving disease modification in dermatology and rheumatology patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MoonLake ImmunotherapeuticsSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Untermüli 7 / Postfach 7444 6302 Zug
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://moonlaketx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/moonlake-immunotherapeutics-ag/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Moonlake Reveals Phase 3 Sonelokimab Trial Results
    Moonlake Reveals Phase 3 Sonelokimab Trial Results

    28 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/28/3264203/0/en/MoonLake-announces-Week-40-Results-from-its-Phase-3-Clinical-Trials-of-Sonelokimab-in-Hidradenitis-Suppurativa-at-the-2026-AAD-Annual-Meeting.html

    GLOBENEWSWIRE
    28 Mar 2026
    Share Share
    Moonlake Arthritis Win Kicks Off Pivotal Year For IL-17 Nanobody
    Moonlake Arthritis Win Kicks Off Pivotal Year For IL-17 Nanobody

    23 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/moonlakes-phase-2-arthritis-win-kicks-pivotal-year-il-17-nanobody

    FIERCE BIOTECH
    23 Feb 2026
    Share Share
    Moonlake Reports Positive Phase 2 Trial Results For Sonelokimab
    Moonlake Reports Positive Phase 2 Trial Results For Sonelokimab

    22 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/22/3242267/0/en/MoonLake-Announces-Positive-Topline-Results-from-its-Phase-2-Clinical-Trial-of-Sonelokimab-in-Axial-Spondyloarthritis-and-Reports-2025-Financial-Results.html

    GLOBENEWSWIRE
    22 Feb 2026
    Share Share
    FDA Fast-Track MoonLake's Sonelokimab for Palmoplantar Pustulosis
    FDA Fast-Track MoonLake's Sonelokimab for Palmoplantar Pustulosis

    02 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/02/3230183/0/en/MoonLake-Announces-FDA-Fast-Track-Designation-for-Sonelokimab-Palmoplantar-Pustulosis-PPP-and-Provides-Details-on-Upcoming-Investor-Day.html

    GLOBENEWSWIRE
    02 Feb 2026
    Share Share
    Moonlake Immunotherapeutics Reports Favorable Type B Meeting
    Moonlake Immunotherapeutics Reports Favorable Type B Meeting

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215344/0/en/MoonLake-Immunotherapeutics-Announces-Positive-Outcome-from-Type-B-Meeting-with-U-S-FDA-and-Announces-Investor-Day.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Moonlake Immunotherapeutics Prices $75M Offering
    Moonlake Immunotherapeutics Prices $75M Offering

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181328/0/en/MoonLake-Immunotherapeutics-Announces-Pricing-of-75-Million-Underwritten-Offering.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search